Influence of local and systemic CTLA4Ig gene transfer on corneal allograft survival

2006 ◽  
Vol 8 (4) ◽  
pp. 459-467 ◽  
Author(s):  
Nianqiao Gong ◽  
Uwe Pleyer ◽  
Jun Yang ◽  
Katrin Vogt ◽  
Marcelo Hill ◽  
...  
2007 ◽  
Vol 245 (10) ◽  
pp. 1515-1521 ◽  
Author(s):  
Daniel Fabian ◽  
Nianqiao Gong ◽  
Katrin Vogt ◽  
Hans-Dieter Volk ◽  
Uwe Pleyer ◽  
...  

Gene Therapy ◽  
2006 ◽  
Vol 14 (6) ◽  
pp. 484-490 ◽  
Author(s):  
N Gong ◽  
U Pleyer ◽  
H-D Volk ◽  
T Ritter

2009 ◽  
Vol 9 (1) ◽  
pp. 33-44 ◽  
Author(s):  
Douglas Parker ◽  
Helen Brereton ◽  
Douglas Coster ◽  
Keryn Williams

2007 ◽  
Vol 18 (2) ◽  
pp. 101-107 ◽  
Author(s):  
Thomas Ritter ◽  
Jun Yang ◽  
Haike Dannowski ◽  
Katrin Vogt ◽  
Hans-Dieter Volk ◽  
...  

2021 ◽  
pp. 1-2
Author(s):  
Björn Bachmann

Corneal allograft survival is mediated by the variety of immunological reactions and wound healing process. Our aim was to explore the effects of topical administration of ripasudil, a selective Rho-associated coiled-coil protein kinase inhibitor, on corneal allograft survival. Ripasudil was administered to mice thrice a day after allogeneic corneal transplantation. Corneal graft survival, opacity, neovascularization, re-epithelization, immune cell infiltration, and mRNA levels of angiogenic and pro-inflammatory factors in the grafted cornea and draining lymph nodes (dLNs) were evaluated with slit-lamp microscopy, immunohistochemistry, flow cytometry, and polymerase chain reaction. Graft survival was significantly prolonged with lower graft opacity and neovascularization scores in 0.4% and 2.0% ripasudil-treated groups, and mRNA levels of angiogenic and pro-inflammatory factors in ripasudil-treated grafted corneas were reduced. Moreover, 0.4% and 2.0% ripasudil reduced CD45<sup>+</sup>-infiltrated leukocyte frequency, <i>Cd11b</i> and <i>Cd11c</i> mRNA levels, and the frequencies of mature dendritic cells, IFNγ-, and IL-17- producing CD4<sup>+</sup>T cells in the dLNs of recipients. Re-epithelization rate of the grafted cornea was significantly higher in the 0.4% and 2.0% ripasudil groups than in the control. Topically applied ripasudil prolonged graft survival by downregulating neovascularization and inflammation factors, while promoting corneal re-epithelization, suggesting that ripasudil may be useful for suppressing immunological rejection in corneal transplantation.


2007 ◽  
Vol 38 (6) ◽  
pp. 457-461 ◽  
Author(s):  
Selim Doganay ◽  
I. Fevzi Hepsen ◽  
Saim Yologlu ◽  
Hakan Demirtas

2019 ◽  
Vol 60 (15) ◽  
pp. 4958 ◽  
Author(s):  
Tomoyuki Kunishige ◽  
Hiroko Taniguchi ◽  
Tatsukuni Ohno ◽  
Miyuki Azuma ◽  
Junko Hori

Ophthalmology ◽  
1993 ◽  
Vol 100 (6) ◽  
pp. 890-896 ◽  
Author(s):  
Jessica K. Milani ◽  
Uwe Pleyer ◽  
Andres Dukes ◽  
H. Joseph Chou ◽  
Sabine Lutz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document